Back on January 8, a jury was selected to hear the case of United States v. Berkeley Premium Netraceuticals (and several of its corporate officers). Earlier today, closing arguments were completed and the jury was given final instructions. Deliberations are set to commence tomorrow morning. (The Enquirer's most recent article on closing arguments, which began last week, is here.) I've never been involved in a trial of this length, and have often wondered how one finds a jury of twelve (plus a couple alternates) who can give up their employment for a month or longer.
Berkeley is the company that manufactures and markets Enzyte, a product which Berekeley claimed (often through ads featuring "Smiling Bob") could enhance a certain part of the male anatomy.
In 2004, the Enquirer reported that Berekeley was a $250 million per year company, employing 1,000 people locally.